DE3686699D1 - P-aminophenole, ihre derivate und verwendung zur herstellung eines medikaments. - Google Patents

P-aminophenole, ihre derivate und verwendung zur herstellung eines medikaments.

Info

Publication number
DE3686699D1
DE3686699D1 DE8686307616T DE3686699T DE3686699D1 DE 3686699 D1 DE3686699 D1 DE 3686699D1 DE 8686307616 T DE8686307616 T DE 8686307616T DE 3686699 T DE3686699 T DE 3686699T DE 3686699 D1 DE3686699 D1 DE 3686699D1
Authority
DE
Germany
Prior art keywords
aminophenols
medicine
derivatives
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686307616T
Other languages
English (en)
Other versions
DE3686699T2 (de
Inventor
Raj N Misra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of DE3686699D1 publication Critical patent/DE3686699D1/de
Application granted granted Critical
Publication of DE3686699T2 publication Critical patent/DE3686699T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686307616T 1985-10-28 1986-10-02 P-aminophenole, ihre derivate und verwendung zur herstellung eines medikaments. Expired - Fee Related DE3686699T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79196485A 1985-10-28 1985-10-28

Publications (2)

Publication Number Publication Date
DE3686699D1 true DE3686699D1 (de) 1992-10-15
DE3686699T2 DE3686699T2 (de) 1993-02-25

Family

ID=25155381

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686307616T Expired - Fee Related DE3686699T2 (de) 1985-10-28 1986-10-02 P-aminophenole, ihre derivate und verwendung zur herstellung eines medikaments.

Country Status (5)

Country Link
US (2) US4814454A (de)
EP (1) EP0221677B1 (de)
JP (1) JPS62120348A (de)
CA (1) CA1285951C (de)
DE (1) DE3686699T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285951C (en) * 1985-10-28 1991-07-09 Raj N. Misra Naphthalenyl- and quinolinyl-amino substituted phenols
EP0254259A3 (de) * 1986-07-21 1989-11-23 Otsuka Pharmaceutical Factory, Inc. p-Aminophenol-Derivate
US5202336A (en) * 1986-09-24 1993-04-13 Bayer Aktiengesellschaft Antiflammatory quinolin methoxy phenylsulphonamides
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
US7071298B2 (en) * 1997-02-05 2006-07-04 Fox Chase Cancer Center Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteins
US20060106102A1 (en) * 2002-06-07 2006-05-18 Eric Morand Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
CA2536788A1 (en) * 2003-08-29 2005-03-10 Pfizer Inc. Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents
JP4948913B2 (ja) 2006-06-16 2012-06-06 上野製薬株式会社 ナフタレンカルボン酸アミドの製造方法
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) * 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
CN101641013B (zh) 2007-01-22 2014-07-30 Gtx公司 核受体结合剂
ES2909884T3 (es) 2013-08-20 2022-05-10 Univ Washington Through Its Center For Commercialization Inhibidores nuevos y específicos de la hidroxilasa del ácido retinoico del citocromo P450 26

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE530825C (de) * 1926-12-14 1931-08-01 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Arylaminonaphthalinderivaten
DE1049701B (de) * 1957-02-21
US3634238A (en) * 1969-03-12 1972-01-11 Mobil Oil Corp Organic compositions containing amines and metals or salts thereof
US3948990A (en) * 1971-03-19 1976-04-06 Imperial Chemical Industries Limited Chemical compounds and compositions
US3819637A (en) * 1971-06-23 1974-06-25 Sterling Drug Inc 1,2-diphenyl-1,2,3,4-tetrahydroquinolines
US3767575A (en) * 1971-11-16 1973-10-23 Mobil Oil Corp Oxidation resistant lubricant compositions
SU636224A1 (ru) * 1977-05-16 1978-12-05 Днепропетровский Химико-Технологический Институт Имени Ф.Э.Дзержинского Способ получени галогенэфиров оксидиариламинов
JPS5869851A (ja) * 1981-10-20 1983-04-26 Ono Pharmaceut Co Ltd アミノレソルシノ−ル誘導体、その製造方法及びその誘導体を有効成分として含有する治療剤
JPS5890534A (ja) * 1981-11-25 1983-05-30 Ono Pharmaceut Co Ltd ２−アミノフエノ−ル誘導体、その製造方法およびその誘導体を有効成分として含有する治療剤
US4423065A (en) * 1982-05-04 1983-12-27 Eli Lilly And Company Naphthalenamine insecticides
CH651034A5 (de) * 1982-05-12 1985-08-30 Hoffmann La Roche Chroman-, thiochroman- oder 1,2,3,4-tetrahydrochinolinderivate und ihre verwendung als arzneimittel-wirkstoffe.
US4492704A (en) * 1982-09-30 1985-01-08 Eli Lilly And Company Quinoline quinones and anti-asthmatic use thereof
US4496590A (en) * 1983-04-18 1985-01-29 Sterling Drug Inc. Benzyl alcohol derivatives, their preparation and use
US4526999A (en) * 1983-04-25 1985-07-02 Merck & Co., Inc. Lipoxygenase inhibitors
US4515980A (en) * 1983-07-11 1985-05-07 Sterling Drug Inc. Substituted aminobenzoates, their preparation and use
US4510139A (en) * 1984-01-06 1985-04-09 Sterling Drug Inc. Substituted aminobenzamides and their use as agents which inhibit lipoxygenase activity
CA1285951C (en) * 1985-10-28 1991-07-09 Raj N. Misra Naphthalenyl- and quinolinyl-amino substituted phenols

Also Published As

Publication number Publication date
CA1285951C (en) 1991-07-09
JPS62120348A (ja) 1987-06-01
EP0221677A2 (de) 1987-05-13
EP0221677A3 (en) 1989-01-25
US4814454A (en) 1989-03-21
US4910208A (en) 1990-03-20
EP0221677B1 (de) 1992-09-09
DE3686699T2 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE69131627D1 (de) Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
DE69008454D1 (de) Nitrolsothiolderivate, ihre Herstellung und Verwendung.
DE3765682D1 (de) Thiolactam-n-essigsaeure-derivate, ihre herstellung und verwendung.
DE3686699D1 (de) P-aminophenole, ihre derivate und verwendung zur herstellung eines medikaments.
DE3869257D1 (de) N-aminobutyl-n-phenylarylamid-derivate, ihre herstellung und ihre verwendung in der heilkunde.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
ATE34392T1 (de) Imidazolinderivate, ihre herstellung und therapeutische verwendung.
DE3883297D1 (de) Phenolderivate, ihre herstellung und verwendung.
DE3863191D1 (de) Substituierte aminderivate, ihre herstellung und verwendung.
DE68908389D1 (de) Amidofluoroverbindungen, ihre herstellung und ihre verwendung.
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
DE3770013D1 (de) Sulfenamidderivate und ihre herstellung.
DE3770299D1 (de) 1,2,4-triazinonderivate, ihre herstellung und verwendung.
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.
DE3686632D1 (de) Antibiotische derivate, ihre herstellung und verwendung.
DE3782698D1 (de) 5-fluoruridin-derivat und dessen herstellung.
DE3779525D1 (de) 5-aminomethyl-2-oxazolidinon-derivate, ihre herstellung und ihre anwendung in der heilkunde.
DE68910893D1 (de) Alkenyltetrazole Derivate, ihre Herstellung und ihre Verwendung.
DE3686113D1 (de) Lymphokin, dessen herstellung und verwendungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee